Literature DB >> 23014481

Mortality risk of triglyceride levels in patients with coronary artery disease.

Takatoshi Kasai1, Katsumi Miyauchi, Naotake Yanagisawa, Kan Kajimoto, Naozumi Kubota, Manabu Ogita, Shuta Tsuboi, Atsushi Amano, Hiroyuki Daida.   

Abstract

OBJECTIVE: The association between triglyceride level and the risk of coronary artery disease (CAD) remains controversial. In particular, the prognostic significance of triglyceride levels in established CAD is unclear. We aimed to assess the relationship between triglyceride levels and long-term (>10 years) prognosis in a cohort of patients after complete coronary revascularisation.
DESIGN: Observational cohort study.
SETTING: Departments of cardiology and cardiovascular surgery in a university hospital. PATIENTS: Consecutive patients who had undergone complete revascularisation between 1984 and 1992. All patients were categorised according to the quintiles of fasting triglyceride levels at baseline. MAIN OUTCOME MEASURES: The risk of fasting triglyceride levels for all-cause and cardiac mortality was assessed by multivariable Cox proportional hazards regression analyses.
RESULTS: Data from 1836 eligible patients were assessed. There were 412 (22.4%) all-cause deaths and 131 (7.2%) cardiac deaths during a median follow-up of 10.5 years. Multivariable analyses including total and high-density lipoprotein cholesterol and other covariates revealed no significant differences in linear trends for all-cause mortality according to the quintiles of triglyceride (p for trend=0.711). However, the HR increased with the triglyceride levels in a significant and dose-dependent manner for cardiac mortality (p for trend=0.031). Multivariable analysis therefore showed a significant relationship between triglyceride levels, when treated as a natural logarithm-transformed continuous variable, and increased cardiac mortality (HR 1.51, p=0.044).
CONCLUSIONS: Elevated fasting triglyceride level is associated with increased risk of cardiac death after complete coronary revascularisation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23014481     DOI: 10.1136/heartjnl-2012-302689

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

Review 1.  Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes.

Authors:  Anastasia-Stefania Alexopoulos; Ali Qamar; Kathryn Hutchins; Matthew J Crowley; Bryan C Batch; John R Guyton
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  Association Between TG-to-HDL-C Ratio and In-Stent Stenosis Under Optical Coherence Tomography Guidance.

Authors:  Ya Li; Peng Jin; Fangjie Hou; Yujie Zhou
Journal:  J Med Syst       Date:  2018-11-20       Impact factor: 4.460

3.  The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.

Authors:  Avi Amrami-Weizman; Rachel Maayan; Irit Gil-Ad; Artashez Pashinian; Camil Fuchs; Moshe Kotler; Michael Poyurovsky
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

Review 4.  A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021.

Authors:  Tahreem Iqbal; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2021-07-11       Impact factor: 2.931

5.  Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-blind, randomized, placebo-controlled study.

Authors:  Jiangtao Lai; Bifeng Wu; Tianming Xuan; Zhong Liu; Junzhu Chen
Journal:  Lipids Health Dis       Date:  2014-01-02       Impact factor: 3.876

6.  Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.

Authors:  Xiao-Lin Li; Li-Feng Hong; Song-Hui Luo; Yuan-Lin Guo; Cheng-Gang Zhu; Jing Sun; Qian Dong; Ping Qing; Rui-Xia Xu; Jun Liu; Sha Li; Na-Qiong Wu; Geng Liu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-04-27       Impact factor: 3.876

Review 7.  Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.

Authors:  Alexander Tenenbaum; Robert Klempfner; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2014-12-04       Impact factor: 9.951

8.  Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease.

Authors:  Li-Feng Hong; Xiao-Ni Yan; Zhen-Hua Lu; Ying Fan; Fei Ye; Qiong Wu; Song-Hui Luo; Bo Yang; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2017-01-13       Impact factor: 3.876

9.  Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysis.

Authors:  Peter P Toth; Sephy Philip; Michael Hull; Craig Granowitz
Journal:  Clin Cardiol       Date:  2019-08-01       Impact factor: 2.882

10.  High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk.

Authors:  Peter P Toth; Craig Granowitz; Michael Hull; Djibril Liassou; Amy Anderson; Sephy Philip
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.